Delivery Order SPE2DB22D1103-SPE2DB24FTND9

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $1,148.54, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of June 18, 2024. It is not associated with a...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the U.S. government. The contract, valued at $1,211.66, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of April 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to...
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA). The $7,033.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product, to the U.S. government. The award, valued at $1,432.01, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA). This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the U.S. government. The $3,227.67 firm-fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is a delivery order off of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. The IDC serves as...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA), a defense agency. The $13,728.70 firm fixed price delivery order has a completion date of May 21, 2025 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2025. The contract is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
The federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,454.37 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of September 6, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for the supply of a comprehensive range...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency, by the prime contractor Amerisourcebergen Drug Corp. The $29,323.35 contract is a firm fixed-price delivery order with a completion date of May 27, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office division. The contract has a firm fixed price of $5,872.20 and an ultimate completion date of August 8, 2023. This is a delivery order contract awarded against a larger Indefinite...
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS (product ID 4566167308) to the Defense Logistics Agency (DLA), a defense agency. The $1,385.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with an ultimate completion date of October 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTND9
    Delivery Order

This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA). The $3,281.82 firm fixed price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. government.

The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order has a completion date of July 9, 2024. The contract does not have a set-aside designation.

Generated 10/7/24, 10:53 AM